![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 15, 10184-10197, April 11, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Cells*



1


2
From the
Department of Physiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada, the
Department of Pharmacology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada, and ¶Mellitech, DRMFC/SC1B, CEA Grenoble, 38054 Grenoble, France
During insulin secretion, pancreatic
-cells are exposed to Zn2+ released from insulin-containing secretory granules. Although maintenance of Zn2+ homeostasis is critical for cell survival and glucagon secretion, very little is known about Zn2+-transporting pathways and the regulation of Zn2+ in
-cells. To examine the effect of Zn2+ on glucagon secretion and possible mechanisms controlling the intracellular Zn2+ level ([Zn2+]i), we employed a glucagon-producing cell line (
-TC6) and mouse islets where non-β-cells were identified using islets expressing green fluorescent protein exclusively in β-cells. In this study, we first confirmed that Zn2+ treatment resulted in the inhibition of glucagon secretion in
-TC6 cells and mouse islets in vitro. The inhibition of secretion was not likely via activation of KATP channels by Zn2+. We then determined that Zn2+ was transported into
-cells and was able to accumulate under both low and high glucose conditions, as well as upon depolarization of cells with KCl. The nonselective Ca2+ channel blocker Gd3+ partially inhibited Zn2+ influx in
-TC cells, whereas the L-type voltage-gated Ca2+ channel inhibitor nitrendipine failed to block Zn2+ accumulation. To investigate Zn2+ transport further, we profiled
-cells for Zn2+ transporter transcripts from the two families that work in opposite directions, SLC39 (ZIP, Zrt/Irt-like protein) and SLC30 (ZnT, Zn2+ transporter). We observed that Zip1, Zip10, and Zip14 were the most abundantly expressed Zips and ZnT4, ZnT5, and ZnT8 the dominant ZnTs. Because the redox state of cells is also a major regulator of [Zn2+]i, we examined the effects of oxidizing agents on Zn2+ mobilization within
-cells. 2,2'-Dithiodipyridine (-SH group oxidant), menadione (superoxide generator), and SIN-1 (3-morpholinosydnonimine) (peroxynitrite generator) all increased [Zn2+]i in
-cells. Together these results demonstrate that Zn2+ inhibits glucagon secretion, and it is transported into
-cells in part through Ca2+ channels. Zn2+ transporters and the redox state also modulate [Zn2+]i.
Received for publication, August 21, 2007 , and in revised form, January 31, 2008.
* This work was supported by Canadian Institutes of Health Research Operating Grant MOP-49521 (to M. B. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 1 and Figs. 1 and 2.
1 Supported by a studentship from Canadian Institute of Health Research.
2 To whom correspondence should be addressed: Dept. of Physiology, University of Toronto, 1 King's College Circle, Rm. 3352, Toronto, Ontario M5S 1A8, Canada. Tel.: 416-978-6737; Fax: 416-978-4940; E-mail: michael.wheeler{at}utoronto.ca.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Diao, E. M. Allister, V. Koshkin, S. C. Lee, A. Bhattacharjee, C. Tang, A. Giacca, C. B. Chan, and M. B. Wheeler UCP2 is highly expressed in pancreatic {alpha}-cells and influences secretion and survival PNAS, August 19, 2008; 105(33): 12057 - 12062. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |